199 related articles for article (PubMed ID: 32289402)
1. Patients with a familial predisposition to hidradenitis suppurativa have a distinct clinical phenotype.
Jørgensen AR; Brøgger-Mikkelsen M; Ring HC; Thomsen SF
J Am Acad Dermatol; 2020 Dec; 83(6):1809-1811. PubMed ID: 32289402
[No Abstract] [Full Text] [Related]
2. Hidradenitis suppurativa in the pediatric population.
Liy-Wong C; Pope E; Lara-Corrales I
J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S36-41. PubMed ID: 26470613
[TBL] [Abstract][Full Text] [Related]
3. Hidradenitis suppurativa, a review of pathogenesis, associations and management. Part 1.
Vekic DA; Frew J; Cains GD
Australas J Dermatol; 2018 Nov; 59(4):267-277. PubMed ID: 29355905
[TBL] [Abstract][Full Text] [Related]
4. Successful Treatment of Severe Recalcitrant Hidradenitis Suppurativa with the Interleukin-17A Antibody Secukinumab.
Schuch A; Fischer T; Boehner A; Biedermann T; Volz T
Acta Derm Venereol; 2018 Jan; 98(1):151-152. PubMed ID: 28902952
[No Abstract] [Full Text] [Related]
5. New insights into the diagnosis of hidradenitis suppurativa: Clinical presentations and phenotypes.
van der Zee HH; Jemec GB
J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S23-6. PubMed ID: 26470610
[TBL] [Abstract][Full Text] [Related]
6. Hidradenitis Suppurativa/Acne Inversa: Criteria for Diagnosis, Severity Assessment, Classification and Disease Evaluation.
Zouboulis CC; Del Marmol V; Mrowietz U; Prens EP; Tzellos T; Jemec GB
Dermatology; 2015; 231(2):184-90. PubMed ID: 26139027
[TBL] [Abstract][Full Text] [Related]
7. Hidradenitis suppurativa in association with keratitis-ichthyosis-deafness syndrome treated with adalimumab.
Song YM; Kim YS; Lee JH; Park YM; Lee JY
J Dermatol; 2018 Sep; 45(9):e262-e263. PubMed ID: 29570225
[No Abstract] [Full Text] [Related]
8. Late-onset hidradenitis suppurativa: A cluster analysis of the National Italian Registry IRHIS.
Cazzaniga S; Pezzolo E; Garcovich S; Naldi L;
J Am Acad Dermatol; 2021 Jul; 85(1):e29-e32. PubMed ID: 33677001
[No Abstract] [Full Text] [Related]
9. Dermal tunnels influence time to clinical response and family history influences time to loss of clinical response in patients with hidradenitis suppurativa treated with adalimumab.
Frew JW; Jiang CS; Singh N; Grand D; Navrazhina K; Vaughan R; Krueger JG
Clin Exp Dermatol; 2021 Mar; 46(2):306-313. PubMed ID: 32931599
[TBL] [Abstract][Full Text] [Related]
10. Pain in Hidradenitis Suppurativa: A Pilot Study.
Ring HC; Sørensen H; Miller IM; List EK; Saunte DM; Jemec GB
Acta Derm Venereol; 2016 May; 96(4):554-6. PubMed ID: 26631388
[No Abstract] [Full Text] [Related]
11. Hidradenitis suppurativa (HS) and Down syndrome (DS): Increased prevalence and a younger age of hidradenitis symptom onset.
Denny G; Anadkat MJ
J Am Acad Dermatol; 2016 Sep; 75(3):632-634. PubMed ID: 27543219
[No Abstract] [Full Text] [Related]
12. Severe refractory hidradenitis suppurativa in an HIV-positive patient successfully treated with infliximab.
Alecsandru D; Padilla B; Izquierdo JA; Fernández-Cruz E; Sánchez-Ramón S
Arch Dermatol; 2010 Dec; 146(12):1343-5. PubMed ID: 21173317
[No Abstract] [Full Text] [Related]
13. A retrospective institutional study of the association of smoking with the severity of hidradenitis suppurativa.
Dessinioti C; Zisimou C; Tzanetakou V; Ntritsos G; Kontochristopoulos G; Antoniou C
J Dermatol Sci; 2017 Aug; 87(2):206-207. PubMed ID: 28442193
[No Abstract] [Full Text] [Related]
14. Prevalence of hidradenitis suppurativa in Brazil: a population survey.
Ianhez M; Schmitt JV; Miot HA
Int J Dermatol; 2018 May; 57(5):618-620. PubMed ID: 29517130
[No Abstract] [Full Text] [Related]
15. Long-term adalimumab treatment of hidradenitis suppurativa: Results and practical insights from a real-life experience.
Bettoli V; Manfredini M; Calamo G; Forconi R; Bencivelli D; Mantovani L; Pellacani G; Corazza M
Dermatol Ther; 2018 Nov; 31(6):e12737. PubMed ID: 30295378
[No Abstract] [Full Text] [Related]
16. Hidradenitis suppurativa and associated factors: still unsolved problems.
Matusiak L; Bieniek A; Szepietowski JC
J Am Acad Dermatol; 2009 Aug; 61(2):362-5. PubMed ID: 19615551
[No Abstract] [Full Text] [Related]
17. [Crohn's disease and hidradenitis suppurativa: An announced crisis?].
Cohen L; Fathallah N; Pommaret E; de Parades V; Cosnes J
Presse Med; 2017; 46(7-8 Pt 1):777-778. PubMed ID: 28751066
[No Abstract] [Full Text] [Related]
18. Dowling-Degos Disease and Hidradenitis Suppurativa. Epidemiological and Clinical Study of 15 Patients and Review of the Literature.
Agut-Busquet E; González-Villanueva I; Romani de Gabriel J; Pascual JC; Ribera Pibernat M; Luelmo J
Acta Derm Venereol; 2019 Sep; 99(10):917-918. PubMed ID: 31120546
[No Abstract] [Full Text] [Related]
19. Two diseases one remedy? Systemic amyloidosis secondary to hidradenitis suppurativa: Treatment with infliximab.
Özer İ; Karaçin C; Adışen E; Güz G; Ali Gürer M
Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 27862787
[TBL] [Abstract][Full Text] [Related]
20. A retrospective study of the characteristics of patients with early-onset compared to adult-onset hidradenitis suppurativa.
Dessinioti C; Tzanetakou V; Zisimou C; Kontochristopoulos G; Antoniou C
Int J Dermatol; 2018 Jun; 57(6):687-691. PubMed ID: 29604044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
